- Home
- FVCB vs KOD Comparison
FVCB vs KOD Comparison
Compare FVCB & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVCB
- KOD
- Stock Information
- Founded
- FVCB 2007
- KOD 2009
- Country
- FVCB United States
- KOD United States
- Employees
- FVCB N/A
- KOD N/A
- Industry
- FVCB Major Banks
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FVCB Finance
- KOD Health Care
- Exchange
- FVCB Nasdaq
- KOD Nasdaq
- Market Cap
- FVCB 248.5M
- KOD 188.9M
- IPO Year
- FVCB N/A
- KOD 2018
- Fundamental
- Price
- FVCB $11.52
- KOD $3.94
- Analyst Decision
- FVCB
- KOD Hold
- Analyst Count
- FVCB 0
- KOD 3
- Target Price
- FVCB N/A
- KOD $9.00
- AVG Volume (30 Days)
- FVCB 35.7K
- KOD 412.3K
- Earning Date
- FVCB 07-24-2025
- KOD 05-14-2025
- Dividend Yield
- FVCB N/A
- KOD N/A
- EPS Growth
- FVCB 311.46
- KOD N/A
- EPS
- FVCB 1.03
- KOD N/A
- Revenue
- FVCB $60,453,000.00
- KOD N/A
- Revenue This Year
- FVCB $8.48
- KOD N/A
- Revenue Next Year
- FVCB $7.88
- KOD N/A
- P/E Ratio
- FVCB $11.28
- KOD N/A
- Revenue Growth
- FVCB 34.53
- KOD N/A
- 52 Week Low
- FVCB $9.49
- KOD $1.92
- 52 Week High
- FVCB $14.50
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- FVCB 51.45
- KOD 54.78
- Support Level
- FVCB $11.41
- KOD $3.26
- Resistance Level
- FVCB $11.89
- KOD $3.81
- Average True Range (ATR)
- FVCB 0.34
- KOD 0.43
- MACD
- FVCB -0.07
- KOD -0.02
- Stochastic Oscillator
- FVCB 35.96
- KOD 66.08
About FVCB FVCBankcorp Inc.
FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.